Stay updated with breaking news from Resolutionrx Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RespireRx Pharmaceuticals (OTC:RSPI) has announced an agreement with Ponto Ventures LLC under which Will Clodfelter will serve as its senior vice president...
ResolutionRx Ltd entered into an agreement with Ab Initio Pharma to manufacture and test a dronabinol lipid nanoparticle formulation for OSA.
Active stocks, known for their frequent price shifts and sustained market interest, are a magnet for savvy investors seeking profits. Let's take a closer look at some of the top OTC stocks from this...
Market temperatures are slowly rising with the summer heat. With some stocks posting double-digit gains, overvaluation concerns are becoming rife. Nevertheless, the focus is increasingly on... -Today at 03:28 am- MarketScreener
RespireRx is moving its cannabinoid program to its subsidiary, ResolutionRx, to develop a dronabinol-based treatment for OSA.